首页> 美国卫生研究院文献>BMJ Open Ophthalmology >Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study

【2h】

Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study

机译：在整个法国的常规临床实践中玻璃体腔内使用阿柏西普治疗与年龄相关的湿性黄斑变性患者的有效性和安全性：RAINBOW研究的12个月结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background/aimsTo monitor treatment-naïve patients with wet age-related macular degeneration (wet AMD) receiving intravitreal aflibercept (IVT-AFL) in France.

机译：背景/目的为了监测法国未接受过湿性年龄相关性黄斑变性（湿性AMD）的初治患者接受玻璃体内阿柏西普（IVT-AFL）的情况。

著录项

期刊名称 BMJ Open Ophthalmology
作者
Michel Weber; Laurent Velasque; Florence Coscas; Céline Faure; Isabelle Aubry; Salomon Y Cohen;
展开▼
作者单位

展开▼
年(卷),期 2019(4),1
年度 2019
页码 e000109
总页数 8
原文格式 PDF
正文语种
中图分类眼科学;
关键词
intravitreal aflibercept wet age-related macular degeneration real-world evidence RAINBOW;

机译：玻璃体腔内使用aiberscept;与年龄相关的湿性黄斑变性;真实证据;彩虹;

相似文献

外文文献
中文文献
专利

1. A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum] [J] . Clinical ophthalmology . 2017,第8期

机译：由研究者发起的单臂研究，用于玻璃体腔注射阿柏西普注射液对先前接受过兰尼单抗或贝伐单抗治疗的渗出性年龄相关性黄斑变性患者的疗效，安全性和耐受性（ASSESS研究）：12个月分析[更正]
2. Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degeneration [J] . Andreas Ebneter, Stephan Michels, Christian Pruente, Scientific reports. . 2020,第1期

机译：瑞士常规治疗中术术术治疗的两年成果，并延长了新生血管年龄相关性黄斑变性的患者方案
3. Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study [J] . Ogura Yuichiro, Terasaki Hiroko, Gomi Fumi, British journal of ophthalmology . 2015,第1期

机译：玻璃体腔注射阿柏西普注射液在湿性年龄相关性黄斑变性中的疗效和安全性：VIEW 2研究的日本亚组的结果
4. Knowledge discovery in ophthalmology: analysis of wet form of Age-related Macular Degeneration treatment outcomes [C] . Magdalena Ulinska, Emanuel Tataj, Jan Mulawka, Conference on photonics applications in astronomy, communications, industry, and high-energy physics experiments . 2009

机译：眼科知识发现：与年龄相关的黄斑变性的湿润形式治疗结果分析
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration in routine clinical practice in France: results from the RAINBOW study [O] . Michel Weber, Laurent Kodjikian, Florence Coscas, 2020

机译：在法国的常规临床实践中玻璃体腔注射阿柏西普给药方案对未接受过治疗的新生血管性年龄相关性黄斑变性患者的影响：RAINBOW研究结果
7. PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration [O] . Nicole Eter, Zoran Hasanbasic, Georgios Keramas, 2021

机译：Perseus 24个月分析：评估德国常规临床实践中术治疗新生血管年龄相关性黄斑变性的常规临床实践中术治疗术语术后临床实践的疗效

Effectiveness and safety of intravitreal aflibercept in patients with wet age-related macular degeneration treated in routine clinical practices across France: 12-month outcomes of the RAINBOW study

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅